Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for PONV in Gynaecological Surgery
NCT02666014Phase 3Completed
- Sponsor
- KK Women's and Children's Hospital
- Start
- Jun 2015
- Primary completion
- Dec 2017
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in postoperative nausea and vomiting (PONV), sponsored by KK Women's and Children's Hospital. Started Jun 2015; status: completed.
02
Drugs
Sugammadex
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02666014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666014.